SCHEMBL2265522

SCHEMBL2265522

O=C(Cl)c1ccncc1C(=O)Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 9/20 0.47
▸ ALDH1A1 P00352 4/20 0.47
▸ KDM6B O15054 4/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ KDM4D Q6B0I6 3/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ KDM4A O75164 2/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ SIRT3 Q9NTG7 1/20 0.45
▸ ROCK2 O75116 1/20 0.43
▸ ROCK1 Q13464 1/20 0.43
▸ GAA P10253 2/20 0.41
▸ GLA P06280 1/20 0.41
▸ ALOX15 P16050 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ NAPRT Q6XQN6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3459640 0.82 KDM4E (0.62) KDM4CALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL22810576 0.82 P2RX1 (0.44) KDM4CALDH1A1KDM6BKDM4EKDM4D
SCHEMBL11590329 0.82 TDP1 (0.42) KDM4CALDH1A1KDM6BKDM4EKDM4D
SCHEMBL587010 0.82 ROCK2 (0.58) KDM4CALDH1A1KDM6BKDM4EKDM4D
SCHEMBL1027774 0.82 GAA (0.45) KDM4CALDH1A1KDM6BKDM4EKDM4D
SCHEMBL30465597 0.82 ROCK2 (0.58) KDM4CALDH1A1KDM6BKDM4EKDM4D
Hydrochloric Acid SCHEMBL10480638 0.81 KDM4E (0.60) KDM4CALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL724581 0.80 ALDH1A1 (0.52) KDM4CALDH1A1KDM6BKDM4EKDM4D
Hydrochloric Acid SCHEMBL2841145 0.80 GAA (0.43) KDM4CALDH1A1KDM6BKDM4EKDM4D
Hydrochloric Acid SCHEMBL2432397 0.80 ROCK2 (0.56) KDM4CALDH1A1KDM6BKDM4EKDM4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651917-A1 DIMERIC IAP INHIBITORS Novartis AG (CH) 2013-10-23 — — EP disclosed
US-20130266590-A1 DIMERIC IAP INHIBITORS NOVARTIS AG (CH) 2013-10-10 — — US disclosed
US-8445440-B2 Dimeric IAP inhibitors NOVARTIS AG (CH) 2013-05-21 — — US disclosed
EP-2539333-A1 DIMERIC IAP INHIBITORS Novartis AG (CH) 2013-01-02 — — EP disclosed
WO-2012080260-A1 DIMERIC IAP INHIBITORS NOVARTIS AG (CH) 2012-06-21 — — WO disclosed
WO-2011104266-A1 DIMERIC IAP INHIBITORS NOVARTIS AG (CH) 2011-09-01 — — WO disclosed
US-20110206690-A1 DIMERIC IAP INHIBITORS NOVARTIS AG (CH) 2011-08-25 — — US disclosed
US-4739062-A REACTING AN AROMATIC COMPOUND WITH DICARBOXYLIC ACID COMPOUND USING METAL HALIDE CATALYST CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 1988-04-19 — — US disclosed
US-3944544-A BACTERICIDE E. R. SQUIBB & SONS, INC. (US) 1976-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130266590-A1 DIMERIC IAP INHIBITORS XIAP, BIRC5, BIRC2 KDM4C 3832/4885ALDH1A1 4312/4885KDM6B 2616/4885
US-20110206690-A1 DIMERIC IAP INHIBITORS XIAP, BIRC5, BIRC2 KDM4C 4210/4885ALDH1A1 4127/4885KDM6B 2755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback